Tumor to liver maximum standardized uptake value ratio of FDG-PET/CT parameters predicts tumor treatment response and survival of stage III non-small cell lung cancer

Table 1 Clinicopathologic characteristics

Characteristics	All cases	Percentage (%)	P (Objective response)
Age(years)
≤ 65	74	69.2	0.291
> 65	33	30.8
Sex
Male	77	72.0	0.131
Female	30	28.0
Smoking history
Yes	65	60.7	0.295
No	42	39.3
Drinking history
Yes	59	55.1	0.514
No	48	44.9
Tumor location
Central	59	55.1	0.008
Peripheral	48	44.9
Histology
SCC	36	33.6	0.053
AC	71	66.4
T stage
1	22	20.5	0.522
2	34	31.8
3	23	21.5
4	28	26.2
N stage
0	6	5.6	0.361
1–3	101	94.4
Tumor stage
IIIA	46	43.0	0.969
IIIB	61	57.0
CEA (median, range)	6.8	0.55–276.1
≤ 7.60	49	45.8	< 0.001
> 7.60	58	54.2
NSE (median, range)	13.8	5.6–66.6
≤ 15.3	59	55.1	0.029
> 15.3	48	44.9
Cyfra21-1(median, range)	4.94	1.04–35.6
≤ 3.95	53	49.5	0.001
> 3.95	54	50.5

ISSN: 1471-2342